Results

eNauka >  Results >  Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo)
Title: Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo)
Authors: Kao, SCH; Reck, M; Liu, SV; Dziadziuszko, R; Hochmair, MJ; Huemer, F; Gilberto, de Castro J; Bernabe, Caro R; Kim, SH; Kowalski, DM;
Andric, Zoran G  ; Oancea, M; Kaul, M; Li, H; Danner, B; Lee, MC; Nabet, BY; Sugawara, S;
Issue Date: 2024
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 35 str. S1638-S1638
DOI: 10.1016/j.annonc.2024.10.667
WoS-ID: 001401985200423
URI: https://enauka.gov.rs/handle/123456789/970647
Project: F. Hoffmann-La Roche, Ltd.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

1
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.